文献速递心脑血管急症重症综合管理与镇静镇痛

基于病因的心源性休克院内生存者预后比较:AMI与非AMI

Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI.
PubMed 文献 · Ann Intensive Care · 2024-05-12
一句话结论心源性休克院内生存者出院后死亡与再住院负担高;非AMI-CS早期死亡风险低于AMI-CS,但1年后死亡风险反超。

该研究基于台湾全民健康保险研究数据库,纳入16,582例心源性休克出院生存者,AMI-CS占42.4%、非AMI-CS占57.6%,随访3年。总体30天、1年、3年死亡率分别为7.0%、24.5%、38.9%,再住院率分别为22.1%、58.2%、73.0%,约40%死亡和60%再住院由心血管问题导致。多变量模型中非AMI-CS组全因死亡(aHR 0.69,95%CI 0.60–0.78)和心血管死亡(aHR 0.65,95%CI 0.54–0.78)风险低于AMI-CS组,但1年后反转为aHR 1.13(95%CI 1.03–1.25)和aHR 1.27(95%CI 1.09–1.49)。AMI-CS与整个观察期内心血管再住院风险相关(aHR 0.80,95%CI 0.76–0.84)。

要点

  • 心源性休克院内生存者出院后负担高:30天、1年、3年死亡率分别为7.0%、24.5%、38.9%,再住院率分别为22.1%、58.2%、73.0%。
  • 非AMI-CS组早期全因死亡(aHR 0.69,95%CI 0.60–0.78)和心血管死亡(aHR 0.65,95%CI 0.54–0.78)风险低于AMI-CS组。
  • 1年后风险反转:非AMI-CS组全因死亡aHR 1.13(95%CI 1.03–1.25)、心血管死亡aHR 1.27(95%CI 1.09–1.49)。
  • 再住院风险未见此反转;AMI-CS与整个观察期内心血管再住院风险相关(aHR 0.80,95%CI 0.76–0.84)。
  • 约40%死亡和60%再住院由心血管问题导致,出院后心血管随访对两类患者均重要。

适用人群与场景

  • 台湾全民健康保险研究数据库中,心源性休克出院后生存的患者,AMI-CS占42.4%、非AMI-CS占57.6%。

研究设计与关键结果

  • 研究类型为基于台湾全民健康保险研究数据库的队列研究,纳入16,582例心源性休克出院生存者,每例随访3年,采用Kaplan-Meier曲线和Cox回归模型分析死亡与再住院。
  • 总体30天、1年、3年死亡率分别为7.0%、24.5%、38.9%,再住院率分别为22.1%、58.2%、73.0%。
  • 心血管问题导致约40%死亡和约60%再住院。
  • 非AMI-CS组因年龄更大、合并症患病率更高,总体死亡负担高于AMI-CS组。
  • 多变量模型中,非AMI-CS组全因死亡风险低于AMI-CS组(aHR 0.69,95%CI 0.60–0.78),心血管死亡风险亦低(aHR 0.65,95%CI 0.54–0.78)。
  • 1年后风险减弱甚至反转:非AMI-CS组全因死亡aHR 1.13(95%CI 1.03–1.25),心血管死亡aHR 1.27(95%CI 1.09–1.49)。
  • 全因再住院和心血管再住院未见此反转;AMI-CS与整个观察期内心血管再住院风险相关(aHR 0.80,95%CI 0.76–0.84)。

证据类型、等级与局限

  • 证据类型:基于台湾全民健康保险研究数据库的队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • AMI-CS院内生存者出院后30天死亡风险和整个观察期内心血管再住院风险较高,提示出院早期需关注心血管事件。
  • 非AMI-CS院内生存者1年后死亡风险反超AMI-CS,提示出院后远期死亡风险需持续关注。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current data on post-discharge mortality and rehospitalization is still insufficient among in-hospital survivors of cardiogenic shock (CS), including acute myocardial infarction (AMI) and non-AMI survivors.

METHODS: Patients with CS who survived after hospital discharge were selected from the Taiwan National Health Insurance Research Database. Each patient was followed up at 3-year intervals. Mortality and rehospitalization were analyzed using Kaplan-Meier curves and Cox regression models.

RESULTS: There were 16,582 eligible patients. Of these, 42.4% and 57.6% were AMI-CS and non-AMI-CS survivors, respectively. The overall mortality and rehospitalization rates were considerably high, with reports of 7.0% and 22.1% at 30 days, 24.5% and 58.2% at 1 year, and 38.9% and 73.0% at 3 years, respectively, among in-hospital CS survivors. Cardiovascular (CV) problems caused approximately 40% mortality and 60% rehospitalization. Overall, the non-AMI-CS group had a higher mortality burden than the AMI-CS group owing to older age and a higher prevalence of comorbidities. In multivariable models, the non-AMI-CS group exhibited a lower risk of all-cause mortality (adjusted hazard ratio [aHR] 0.69, 95% confidence interval [CI] 0.60 to 0.78) and CV mortality (aHR 0.65, 95% CI 0.54 to 0.78) compared to the AMI-CS group. However, these risks diminished and even reversed after one year (aHR 1.13, 95% CI 1.03 to 1.25 for all-cause mortality; aHR 1.27, 95% CI 1.09 to 1.49 for CV mortality).This reversal was not observed in all-cause and CV rehospitalization. For rehospitalization, AMI-CS was associated with the risk of CV rehospitalization in the entire observation period (aHR:0.80, 95% CI:0.76-0.84).

CONCLUSIONS: In-hospital AMI-CS survivors had an increased risk of CV rehospitalization and 30-day mortality, whereas those with non-AMI-CS had a greater mortality risk after 1-year follow-up.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Chien SC, Wang CA, Liu HY, et al. Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI. Ann Intensive Care. 2024. PMID: 38735891. doi:10.1186/s13613-024-01305-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。